The microRNA pathway has been implicated in the regulation of synaptic protein synthesis and ultimately in dendritic spine morphogenesis, a phenomenon associated with long-lasting forms of memory. However, the particular microRNAs (miRNAs) involved are largely unknown. Here we identify specific miRNAs that function at synapses to control dendritic spine structure by performing a functional screen. One of the identified miRNAs, miR-138, is highly enriched in the brain, localized within dendrites and negatively regulates the size of dendritic spines in rat hippocampal neurons. miR-138 controls the expression of acyl protein thioesterase 1 (APT1), an enzyme regulating the palmitoylation status of proteins that are known to function at the synapse, including the α 13 subunits of G proteins (Gα 13 ). RNA-interference-mediated knockdown of APT1 and the expression of membrane-localized Gα 13 both suppress spine enlargement caused by inhibition of miR-138, suggesting that APT1-regulated depalmitoylation of Gα 13 might be an important downstream event of miR-138 function. Our results uncover a previously unknown miRNA-dependent mechanism in neurons and demonstrate a previously unrecognized complexity of miRNA-dependent control of dendritic spine morphogenesis.
The functioning of the mammalian brain relies on the proper formation of intricate neuronal circuits. Neurons within these circuits are synaptically connected, and most excitatory synaptic connections between neurons form on dendritic spines, specialized protrusions emanating from the dendritic shaft 1, 2 . The structural and functional plasticity of dendritic spines correlates with long-lasting changes in synaptic transmission that underlie higher cognitive functions 3, 4 . Dendritic spine abnormalities are a hallmark of a variety of neurological diseases, including several forms of learning disability 5 . A plethora of molecular mechanisms involved in dendritic spine plasticity have been elucidated during the last decade, including actin cytoskeletal dynamics, post-translational protein modifications, protein trafficking, gene transcription and protein turnover [6] [7] [8] [9] [10] . The synthesis of proteins de novo is of particular importance for creating enduring changes in synaptic transmission that are associated with long-term memory 11, 12 . Proteins can be either synthesized in the soma and transported to dendritic spines, or synthesized locally from a pool of dendritic messenger RNAs within or next to spines [13] [14] [15] . The local translation of dendritic mRNAs is regulated tightly by RNAbinding proteins and non-coding RNAs that bind preferentially to the 3ʹ untranslated region (UTR) of the mRNAs 16, 17 . miRNAs, a diverse class of 20-24-nucleotide non-coding RNAs, regulate local mRNA translation in dendrites, thereby affecting the morphology of dendritic spines in rat hippocampal neurons 18, 19 . miRNAs are expressed in essentially all cell types and regulate important biological processes, including differentiation, apoptosis and cellular transformation 20, 21 . miRNAs inhibit mRNA translation by binding to cognate sites in the 3ʹ UTR of target mRNAs 22 . In the mammalian nervous system, miRNAs function during cell specification (miR-124a and miR-9), neurite outgrowth (miR-132) and spine development (miR-134) 23 . Microarray and cloning experiments have shown that a large number of miRNAs are expressed in the postnatal mammalian brain at times of synapse development, but their role in synapse formation and plasticity is largely unknown [24] [25] [26] . Here we present a functional screen that led to the identification of miRNAs that are involved in dendritic spine morphogenesis. Among these miRNAs, miR-138 was found to robustly inhibit the growth of dendritic spines, an effect that was mediated by downregulation of APT1, an enzyme catalysing the depalmitoylation of several signalling proteins 27 . Our findings define a previously unknown mechanism by which miRNAs control dendritic spine morphogenesis and indicate a hitherto unrecognized complexity of miRNA function in the regulation of synaptic plasticity in mammalian neurons.
ResulTs

large-scale identification of synaptically enriched miRNAs
To identify miRNAs that function during synaptic development, we undertook a combination of expression profiling of miRNAs in the synaptodendritic compartment and subsequent functional inhibitory screening in primary hippocampal neurons.
We reasoned that miRNAs that are important for synapse function might reside primarily near the synapse, where they could locally regulate the translation of critical target mRNAs. Synaptosomes, a biochemical fraction highly enriched for synaptic membranes, preserve components of local protein synthesis, including polyribosomes, mRNAs and regulatory RNAs (ref. 28 , Fig. 1a , and data not shown). We therefore conclude that synaptosomes are a suitable source for synaptic miRNAs. Total RNA was extracted from postnatal day 15 (P15) rat forebrains and synaptosomes and simultaneously hybridized to microarrays that contained probes for all mouse and rat mature miRNAs listed in the Sanger database (miRBase, version 7.1; http://www.sanger.ac.uk/Software/Rfam/mirna/). In this manner we identified ten mature miRNAs that displayed an at least twofold enrichment in synaptosomes compared with whole forebrain in three biological replicates. Conversely, four mature miRNAs were strongly depleted from synaptosomes ( Fig. 1b, c ; Supplementary Information, Table S1 ).
The observed enrichment of several miRNAs in RNA preparations from synaptosomes was validated for selected candidates by northern blot analysis (Fig. 2a) . In accordance with the microarray data, we found higher levels of miR-218 (3.02-fold) and miR-138 (1.67-fold) in total RNA prepared from synaptosomes than in whole forebrain. In contrast, mature miR-124 was not enriched (0.96-fold) and pre-miR-124 was undetectable in synaptosomes, confirming that only specific miRNAs are enriched at the synapse. a b FB S1 S2 P2 SYN mmu-miR-126-3p rno-miR-126 S-mmu-miR-133b* S-mmu-miR-328* rno-miR-145 mmu-miR-145 rno-miR-150 mmu-miR-150 mmu-miR-143 rno-miR-143 mmu-miR-224 S-mmu-miR-363* S-rno-miR-219-2 rno-miR-21 mmu-miR-380-3p mmu-miR-377 mmu-miR-138 rno-miR-9 S-mmu-miR-384* rno-miR-98 mmu-miR-376b rno-miR-138 mmu-miR-335 rno-miR-335 mmu-miR-9 S-rno-miR-9-3 mmu-miR-341 rno-miR-341 mmu-miR-137 rno-miR-137 mmu-miR-218 rno-miR-218 mmu-miR-7 rno-miR-7 mmu-miR-29a rno-miR-29a To monitor the subcellular localization of miRNAs identified in our screen, we performed in situ hybridization (ISH) in rat hippocampal neurons at 18 days in vitro (DIV), using probes for miR-9, miR-218, miR-138 and miR-124 as a control (Fig. 2b) . All candidate miRNAs were readily detected in cultured hippocampal neurons by using locked nucleic acid (LNA) oligonucleotides as detection probes. We confirmed the specificity of our ISH protocol by using a scrambled LNA control oligonucleotide (Fig. 2b, upper left panel) . Neuronal expression of miR-138 was further confirmed by ISH in brain slices ( Supplementary Information, Fig. 1a, b) , quantitative RT-PCR and northern blotting with RNA from dissociated primary neurons ( Supplementary Information, Fig. 1c, d ). Whereas miR-124 was localized mainly within the cell body (Fig. 2b, asterisks) , the signals for miR-138, miR-218 and miR-9 extended well into neuronal processes that were identified as dendrites by co-staining for the dendritic marker protein MAP2 (Fig. 2b, arrowheads) . Quantification of the ISH signals (Fig. 2b , lower right panel) confirmed the enrichment of miR-138, miR-218 and miR-9 in dendrites relative to the cell-body-restricted miR-124. Taken together, our microarray, northern blot and ISH data show that a specific subset of miRNAs is enriched in the synaptodendritic compartment of rat neurons. These findings suggest the existence of a dendritic miRNA regulatory network.
Functional screening identifies miR-138 as a negative regulator of dendritic spine size
To study the functional relevance of the miRNA regulatory network in dendrites, we interfered with the function of candidate miRNAs identified in the microarray analysis by transfecting cells with miRNA antagonists (2ʹ-O-methyl (2ʹO-Me) modified antisense (AS) oligoribonucleotides) 29 . We speculated that some of the miRNAs identified in the screen might affect dendritic spine morphology, a correlate of the maturity and strength of excitatory synapses 3, 4, 30 (Fig. 3a) . Using a single cell fluorescent sensor assay 31 , we found that transfection of 2ʹO-Me AS oligonucleotides significantly decreased miRNA-mediated sensor cleavage for three selected miRNAs (miR-138, miR-132 and miR-218) that are endogenously expressed in hippocampal neurons (10-18 DIV; Supplementary Information, Fig. 1e ). Therefore, 2ʹO-Me AS oligonucleotides are suitable for achieving specific inhibition of individual miRNAs. We analysed candidate miRNAs that showed an at least twofold enrichment in synaptosomes compared with whole brain. In addition, miR-132 was included because it regulates dendritic outgrowth 32 . Inhibition of miRNA function by 2ʹO-Me AS oligonucleotides resulted in a significant change in dendritic spine volume for two of the miRNAs tested (miR-138 and miR-132) in comparison with control transfected neurons (Fig. 3b) . Inhibition of miR-138 function resulted in a robust and significant increase in spine volume (Fig. 3b, c) without altering the total number of synaptic puncta ( Supplementary Information, Fig. 2a ). Introducing 2ʹO-Me AS oligonucleotides directed against the other nine candidate miRNAs or three control sequences (2ʹO-Me control, 2ʹO-Me let7c and 2ʹO-Me-126) did not significantly affect spine volume (Fig. 3b) , demonstrating that we can specifically interfere with dendritic spine morphogenesis.
Because inhibition of miR-138 changed dendritic spine size very robustly, and the role of miR-138 in the nervous system and synaptic development was completely unknown, we decided to focus on miR-138. To corroborate our findings, we employed another AS oligonucleotide inhibitor of different chemistry (LNA). Similarly to 2ʹO-Me-138, transfection of LNA-138 specifically increased the average spine volume of hippocampal neurons (Fig. 3d) . Conversely, transfection of miR-138 duplex RNA significantly decreased average spine volume, supporting an inhibitory role for miR-138 in spine growth (Fig. 3e) . miR-138 duplex RNA, but not a control RNA (let-7c), was able to completely revert the spine-growth-promoting effect observed on inhibition of miR-138, demonstrating the specificity of the effect on spine size (Fig. 3f) . Overexpression of either duplex RNA had no significant effect on dendritic spine density or the dendritic branching index ( Supplementary  Information, Fig. 2b, c) , indicating that overall dendritic morphology was not compromised by the introduction of synthetic small RNAs.
We therefore identified miR-138 as a critical component of a regulatory pathway that orchestrates dendritic spine growth. Calcium influx into cortical neurons as induced by membrane depolarization led to a rapid and progressive decline of pre-miR-138 expression ( Supplementary Information, Fig. 2d ) and miR-138 cleavage activity ( Supplementary Information, Fig. 2e ), indicating that miR-138 could be regulated during activity-dependent spine development.
miR-138 regulates synaptic transmission and α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) surface staining
We next examined whether the observed changes in spine morphology on perturbation of miR-138 are associated with corresponding alterations in excitatory synaptic function. We recorded miniature excitatory postsynaptic currents (mEPSCs; Fig. 4a ) from cultured hippocampal neurons that had been transfected with miR-138, with control duplex RNA or with a vector expressing green fluorescent protein (GFP) only. In miR-138-expressing neurons, the median amplitude of mEPSCs was significantly decreased in comparison with both control transfections (Fig. 4b, c) . The frequency of events was not different between all three types of cell. This result is consistent with our previous observations that miR-138 expression leads to a 25% decrease in spine volume ( Fig. 3d ) but has no effect on spine density ( Supplementary  Information, Fig. 2b ). mEPSCs were sensitive to 6-cyano-7-nitroquinoxaline (CNQX) and were therefore largely mediated by AMPARs (data not shown). Accordingly, we found a decrease in the median size, but not in the density, of GluR2-containing AMPAR clusters in dendrites of miR-138-expressing neurons ( Fig. 4d and data not shown; P < 0.001 (Kolmogorov-Smirnov test). Thus, miR-138-mediated spine shrinkage correlates with a decrease in the amplitude of postsynaptic currents and AMPAR cluster size.
mRNA encoding acyl-protein thioesterase 1 (APT1) is a miR-138 target in neurons
Using the RNAhybrid program we predicted miR-138 target mRNAs that might mediate the miR-138 effect on spine morphogenesis 33, 34 . We selected four putative miR-138 target mRNAs that seemed to be particularly interesting in terms of synaptic function: EphrinB3 (ref. To validate the functionality of the identified binding sites within these mRNAs, full-length 3ʹ UTRs of the candidate miR-138 targets were cloned downstream of the luciferase coding region and these constructs were transfected into cortical neurons along with miR-138 duplex RNA. The APT1 3ʹ UTR conferred the most robust decrease in luciferase activity upon miR-138 co-transfection in both HeLa cells lacking endogenous miR-138 and primary neurons ( Fig. 5a ; Supplementary Information, Fig. 3a ). We therefore decided to focus on APT1 and study its regulation by miR-138 in more detail. Introduction of miR-138 into cortical neurons did not significantly alter steady-state APT1-luciferase mRNA levels ( Supplementary Information, Fig. 3b ), suggesting that the inhibitory effect of miR-138 on APT1 expression is due mainly to impaired translation of APT1 mRNA. APT1 catalyses the removal of palmitate, a lipid modification with important roles in the localization and function of proteins 39 . The expression and function of APT1 in the nervous system were completely unknown, but the fact that dynamic palmitoylation of synaptic proteins has been implicated in the regulation of synaptic efficacy 40 made APT1 an interesting candidate in the context of dendritic spine morphology. To test for the physiological significance of the interaction of miR-138 with the APT1 3ʹ UTR we explored the expression of APT1 mRNA and protein with the use of brain slices and isolated primary neurons. By ISH, mouse APT1 mRNA was detected in multiple brain regions, including the principal layers of the hippocampus (Fig. 5b, data not shown) . In hippocampal neurons, APT1 mRNA localized to the somatic and dendritic compartment (Fig. 5c) . In a similar manner to the known dendritic mRNA encoding MAP2, APT1 mRNA was concentrated in granulelike structures along the length of dendrites (Fig. 5d) . APT1 protein protein expression is upregulated during the development of primary cortical neurons in culture. Whole cell extracts were prepared from the indicated stages of cortical neuron development and simultaneously probed with a rabbit antiserum against APT1 (lower band) and a mouse monoclonal anti-β-actin antibody as a loading control (upper band). (f) APT1 protein is present at low levels in synaptosomal extracts. P15 rat brains were fractionated into cytosolic fractions (S1 and S2), membrane fraction (P2) and synaptosomes (SYN), and fractions were probed for the presence of PSD-95, APT1 and TuJ1 as a loading control. Protein levels in whole forebrain before fractionation (WB) are shown for comparison.
gradually increased over three weeks of cortical neuron development in vitro (Fig. 5e) . At the subcellular level, APT1 protein was present in both the cytosolic fractions (low-speed and high-speed centrifugation supernatants) and membrane fractions (high-speed centrifugation pellet and synaptosomes) of P15 rat brain (Fig. 5f ). However, in contrast with PSD-95, most of the APT1 protein accumulated in the soluble cytosolic fractions. These results are consistent with the idea that at least part of the negative regulatory interaction between miR-138 and APT1 mRNA occurs locally in the synaptodendritic compartment.
We next tested whether the predicted miR-138-binding site within the APT1 3ʹ UTR is sufficient for miR-138-mediated translational inhibition. The duplex between the target site of the APT1 3ʹ UTR and miR-138 features extensive complementarity, especially within a highly conserved region at the 5ʹ end of the miRNA known as the 'seed' region (Fig. 6a) . Accordingly, point mutations within this seed region (APT1 mutant) rendered the APT1-luciferase construct insensitive to miR-138-mediated inhibition (Fig. 6b) . Therefore, inhibition of APT1 expression by miR-138 is mediated through a single conserved miR-138-binding site within the APT1 3ʹ UTR. To test whether endogenous miR-138 regulates the translation of APT1 mRNA in neurons, we transfected the APT1-luciferase reporter into mature, miR-138-expressing neurons (14-16 DIV; Fig. 6c ). Inhibition of endogenous miR-138 by 2ʹO-Me-138 specifically upregulated APT1-luciferase expression in a dose-dependent manner. This inhibitory function of endogenous miR-138 on the APT1 reporter construct was dependent on a functional miR-138-binding site ( Fig. 6c; Supplementary Information, Fig. 3c ). The effect of 2ʹO-Me-138 on APT1 expression was specific, because it was effectively competed for by the transfection of miR-138 duplex RNA ( Supplementary Information, Fig. 3d ). Quantitative transduction of primary neurons by bath application of cholesterol-modified 2ʹO-Me-138 led to a reproducible and specific upregulation of APT1 protein as assessed by semi-quantitative western blotting (Fig. 6d) . In summary, our results establish APT1 mRNA as a genuine miR-138 target, thereby implicating miR-138 in the regulation of palmitoylation in neurons.
APT1 activity is required for spine enlargement caused by miR-138 inhibition
We next explored whether the decrease in dendritic spine volume on overexpression of miR-138 might be causally linked to decreased APT1 expression. First, we monitored spine volume in neurons in which endogenous APT1 levels were decreased by RNAi. As judged by western blotting, three out of four APT1 small hairpin RNAs (shRNAs) targeting different regions of the APT1 mRNA effectively decreased endogenous APT1 protein concentration in cortical neurons ( Fig. 7a ; Supplementary Information, Fig. 4b ) and ectopically expressed APT1 in HEK293 cells ( Supplementary Information, Fig. 4a ). In hippocampal neurons, APT1 knockdown by each of the effective shRNAs (APT1 shRNA-1, shRNA-3 and shRNA-4) led to a significant decrease in the size of dendritic protrusions compared with control conditions (Fig. 7b, c , and data not shown). Reduced spine volume on APT1 knockdown was accompanied by a significant decrease in the number of spine-associated PSD-95 clusters within dendrites ( Supplementary  Information, Fig. 4c-e) . None of the APT1 shRNAs had an effect on the total number of dendritic protrusions of hippocampal neurons ( Supplementary Information, Fig. 5a ) or the dendritic branching index ( Supplementary Information, Fig. 5b) , indicating a specific effect of APT1 knockdown on spine morphology. APT1-dependent control of dendritic spine morphology required the depalmitoylating activity of APT1, because inhibition of APT1 enzymatic activity by two different small-molecule inhibitors (FD196 and FD253) similarly led to a decrease in dendritic spine volume ( Fig. 7d ; Supplementary Information, Fig. 5c ), whereas an inactive control compound (RB020) had no effect.
We next tested whether elevated APT1 levels resulting from inhibition of miR-138 are required for the increase in spine volume. A decrease in APT1 levels brought about by APT1 shRNA-3 in miR-138-depleted cells completely suppressed the spine-growth-promoting effect of miR-138 inhibition by 2ʹO-Me-138 (Fig. 7e) and LNA-138 ( Supplementary Information, Fig. 5d ). Conversely, transfection of an APT1 expression construct harbouring a mutation in the miR-138-binding site (APT1 mut), but not a wild-type APT1 construct, efficiently rescued spine shrinkage caused by elevated miR-138 levels (Fig. 7f) . Taken together, these two lines of evidence strongly suggest that APT1 is a critical downstream effector of miR-138 in the regulation of spine morphogenesis.
Membrane localization of the APT1 substrate G protein α 13 (Gα 13 ) counteracts spine enlargement caused by miR-138 inhibition
We investigated the molecular mechanism that underlies dendritic spine enlargement caused by increased APT1 protein levels on inhibition of miR-138. APT1 depalmitoylates several substrates implicated in synaptic plasticity, including endothelial nitric oxide synthase (eNOS), H-Ras and G-protein α subunits, namely Gα 13 (ref. 27) . Because Gα 13 palmitoylation is required for plasma membrane localization and Rho-dependent signalling 41 , we focused on this subunit. We found that a significant fraction of overexpressed Myc-Gα 13 redistributes from the cytosol to the membrane on shRNA-mediated knockdown of endogenous human APT1 (hAPT1) in HEK293 cells (Fig. 8a-c) . In contrast, transfection of an APT1 expression construct (CFP-APT1) had the opposite effect. Thus, APT1 is necessary and sufficient for proper Gα 13 membrane localization in HEK293 cells, presumably by regulating Gα 13 depalmitoylation. More importantly, the introduction of synthetic miR-138 duplex RNA similarly increases the membrane association of Myc-Gα 13 (Fig. 8d, e) . miR-138 had no effect on the subcellular distribution of the cytosolic β-actin or membrane-associated calnexin proteins (Fig. 8d) . Redistribution of Gα 13 coincides with a decrease in endogenous hAPT1 protein levels in miR-138-transfected HEK293 cells (Fig. 8f) .
Finally, we investigated the significance of the regulation of Gα 13 subcellular localization by miR-138 for the control of spine size. In a similar manner to APT1 knockdown (Fig. 7f) , overexpression of wild-type Gα 13 was able to suppress the spine-growth-promoting effect caused by miR-138 inhibition (Fig. 8g) . A palmitoylation-deficient Gα 13 (Gα 13 CCSS) was ineffective in the rescue experiment, demonstrating that Gα 13 palmitoylation is required for miR-138-mediated spine shrinkage. The effects of Gα 13 palmitoylation are probably due to a redistribution of Gα 13 from the cytosol to the membrane, because a constitutively membrane-attached, myristoylated Gα 13 rescues spine morphology in the context of mutated palmitoylation sites (Myr Gα 13 CCSS; Fig. 8g) . The different subcellular localization of the Gα 13 variants was confirmed by cellular fractionation (Fig. 8h) and immunostaining ( Supplementary  Information, Fig. 6a-c) .
We conclude that miR-138 might inhibit spine growth, at least in part, by increasing the membrane localization of Gα 13 , resulting in elevated activity of the downstream RhoA signalling pathway ( Supplementary  Information, Fig. 6d ).
DiscussiON miRNAs have recently emerged as important regulators of nervous system function in vertebrates, for example during neuronal differentiation (miR-9 and miR-124), neuronal outgrowth (miR-132) and dendritic spine morphogenesis (miR-134) 23 . However, a systematic assessment of miRNA function, based on their temporal and subcellular expression in the brain, has not yet been achieved. In this study we generated a comprehensive list of miRNAs residing within the synaptodendritic compartment, and subsequently probed their function in the regulation of dendritic spine morphology. In this manner we identified two neuronal miRNAs (miR-132 and miR-138) that regulate dendritic spine size in an antagonistic manner. Two recent reports suggest that miRNAs beyond those identified here might participate in local translational control in dendrites 42, 43 . There is little overlap between those studies and ours, which might be due to the different sample materials (that is, synaptosomes versus cultured neurons, and adult brain versus P15 brain) and methodologies (microarray versus multiplex RT-PCR) used. However, we note that we might have missed low-expressed miRNAs in dendrites as a result of our very stringent selection criteria. In addition, some of the miRNAs that we identified by microarray might have a function in dendrites that we were unable to uncover with our experimental setup. A more in-depth functional analysis of individual miRNAs identified here will improve our understanding of the dendritic miRNA network.
On the basis of multiple lines of evidence, APT1 mRNA is a genuine miR-138 target in neurons. Studies in other cell systems document a role for APT1 in the depalmitoylation of several signalling proteins, including H-Ras, Gα subunits and eNOS. Although it was known that these APT1 substrates are important in synapse development, our results provide direct evidence for a biological function of APT1-dependent depalmitoylation in neurons during spine development. Using classical epistasis experiments, we found that Gα 13 is one critical APT1 substrate in spine morphogenesis. Although monitoring Gα 13 palmitoylation in neurons proved technically challenging, our results showing that miR-138 controls the membrane localization of Gα 13 in non-neuronal cells (Fig. 8d, e) and that Gα 13 palmitoylation is required for miR-138-dependent regulation of spine size (Fig. 8g ) strongly suggest that miR-138 controls the level of Gα 13 palmitoylation by means of APT1. Further work is needed to elucidate additional substrates of APT1 in neurons, and whether perturbation of miR-138 affects their palmitoylation. Obvious candidates besides Gα 13 subunits include G-protein-coupled receptors, Fyn, Ras, eNOS and PSD-95, all of which are anchored to the spine membrane by means of palmitoylation 40 . Given that miRNAs usually regulate many target mRNAs, miR-138 probably possesses physiologically relevant targets other than APT1. For example, EphrinB3 and RIMS2 contain canonical miR-138 seed matches in their 3ʹ UTR, but none of them showed a significant downregulation on miR-138 overexpression in neurons. The failure of these mRNAs to respond to miR-138 might be due to a low accessibility of the respective target sites in neurons (G.O., unpublished observation).
A major outcome of our study is that miRNA regulation in dendritic spines seems to converge on the translation of critical components of G-protein signalling pathways that impinge on the actin cytoskeleton ( Supplementary Information, Fig. 6d ). For example, miR-134 inhibits the expression of Limk1, a kinase that phosphorylates cofilin, an actin-binding protein that has been implicated in the regulation of dendritic spine and growth cone structure 44 . miR-132 has previously been shown to downregulate p250GAP, an important negative regulator of the spine-growthpromoting GTPases Rac and Cdc42 (ref. 32) . In this study we provide evidence that miR-138 mediates its effect on spine structure, at least in part, by regulating the depalmitoylation enzyme APT1. Among the known APT1 substrates is Gα 13 , an activator of Rho downstream of G-proteincoupled receptors 45 . A miR-138-mediated increase in Gα 13 palmitoylation and membrane localization could result in elevated Rho activity, which in turn could trigger spine shrinkage 46 . This novel miRNA-dependent layer of regulation of critical actin signalling components could help to adapt cytoskeletal changes in individual spines to changes in synaptic activity 6 . Our electrophysiological measurements show that miR-138-mediated spine shrinkage is correlated with decreased postsynaptic function. Although the effects on mEPSC amplitudes are subtle, our results show a significant contribution of a neuronal miRNA to basal excitatory synaptic transmission. The method of regulation of miR-138 activity by stimuli that affect synapse morphology and function is an important topic for future studies. Our preliminary results indicate that, consistent with its spine growth inhibitory effect, miR-138 expression and activity are negatively regulated by calcium influx ( Supplementary Information, Fig. 3d, e) . It remains to be determined whether activity-dependent regulation of miR-138 occurs at the level of precursor processing, as suggested by our previous results 47 , or by a different mechanism. Nevertheless, it is an intriguing possibility that neuronal activity could regulate the expression and/or activity of a variety of synaptic miRNAs. This in turn could contribute to activity-dependent fine-tuning of signalling pathways that coordinate the structural and functional plasticity of spine synapses.
MeTHODs
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology ) of rat embryos (E18) were nucleofected with 2-3 µg of total DNA per condition and plated on six-well dishes in DMEM-Glutamax containing 10% fetal bovine serum (FBS; Invitrogen). After 5 h, medium was replaced with standard neuronal culture medium. Cholesterol-modified 2ʹO-Me-oligonucleotides ('antagomirs'; Thermo Scientific) were applied at 13 DIV at 1 µM in conditioned culture medium for 24 h, and cells were lysed at 18 DIV.
HEK293 cells were maintained in DMEM (Invitrogen) plus 10% FBS, 1 mM glutamine, 100 U ml −1 penicillin and 100 µg ml −1 streptomycin. Transfections were performed with the calcium phosphate method with a final CaCl 2 concentration of 0.1 M and an incubation time of 6-16 h.
DNA constructs. The pSUPER RNAi expression system (Oligoengine) was used for siRNA-mediated knockdown of APT1 in cell culture. Four independent pSU-PER constructs (APT1 shRNA-1-4) were generated with the BglII and HindIII restriction sites. pSUPER plasmids were used either at 10 ng ml −1 (primary neurons) or 200 ng ml −1 (HEK293 cells). An expression vector for full-length mouse APT1 cDNA was obtained from OriGene (MC201121). A version with a mutated miR-138-binding site within the APT1 3ʹ UTR (APT1 mutBS) was generated with the QuikChange Site-Directed Mutagenesis Kit (Stratagene). For generation of an expression vector for Myc-tagged Gα 13 , the mouse Gα 13 open reading frame was PCR-amplified from the pCIS-Gα 13 expression vector (provided by S. Offermanns) and then cloned into pcDNA 3.1/Myc-His A (Invitrogen) using BamHI and XbaI. See Supplementary Methods for primer sequences.
Preparation of synaptoneurosomes. Synaptoneurosomes were prepared from P15 Sprague-Dawley rat pups (Charles River, Sulzfeld, Germany) as described previously 48 .
Microarray. See Supplementary Methods for details.
Northern blot analysis. Northern blots to detect neuronal miRNAs and U6 snRNA were performed as described, with radiolabelled DNA oligonucleotides as probes 19 .
Western blot analysis. Proteins were separated by SDS-PAGE and blotted onto a poly-vinylidene difluoride (PVDF) membrane. Non-specific bindings were blocked with Tris-buffered saline plus 5% milk powder and 0.2% Tween 20. The following primary antibodies were used: polyclonal rabbit anti-APT1 (1:1,000 dilution; the anti-APT1 antibody was produced in rabbit from BioGenes (Berlin, Germany) by using purified hAPT1 (provided by R. Vetter)), mouse anti-PSD95 (1:1,000; MA1-046; Dianova), mouse anti-cMyc (sc40; Santa Cruz), mouse anti-HA (1583816; Roche), mouse anti-β 3 -tubulin (1:15,000; MMS-435P; Covance), mouse anti-EEA1 (1:10,000; 610456; Becton Dickinson), rabbit anti-calnexin (SPA-865; Stressgen) and mouse anti-β-actin (A5441; Sigma). Primary antibodies were recognized either by a horseradish peroxidase (HRP)-conjugated goat anti-rabbit antibody (1:20,000; 401315; Calbiochem) or an HRP-conjugated rabbit anti-mouse antibody (1:20,000; 402335; Calbiochem). Secondary antibodies were detected by enhanced chemiluminescence with the ECL Plus Western Blotting Detection System (GE Healthcare).
Image analysis. For image analysis, neurons were transfected at 10 DIV or 14 DIV with indicated miRNAs, miRNA inhibitors or siRNA expression vectors in combination with enhanced GFP and processed for confocal microscopy at 18 DIV.
For spine analysis, high-resolution z-stack images of GFP-positive neurons were taken with a confocal laser scanning microscope (Zeiss). Random neurons displaying pyramidal morphology were chosen from data sets that had been blinded to the experimental condition. Spine volumes were subsequently analysed with the ImageJ software. At least 15 individual neurons derived from three independent experiments were measured for each experimental condition. For the functional screen 50 spines per neuron were analysed; for subsequent analyses more than 100 spines per n euron were analysed. For Sholl analysis, low-magnification pictures of GFP-positive neurons were taken and dendritic complexity was analysed with ImageJ software. At least ten individual neurons for each experimental condition of a total of three independent experiments were measured. For details on spine analysis and Sholl analysis see ref. 19 . The determination of synapse density was performed by the method of ref. 49. The size of GluR2 surface clusters was determined with the Analyze Particle function of ImageJ, using thresholded images. Particles smaller than 0.1 µm 2 were excluded from the analysis.
Luciferase assay. Cortical or hippocampal neurons were transfected at 4 DIV or 14-16 DIV, and luciferase assays were performed one or two days later with the Dual-Luciferase Reporter Assay System (Promega).
In situ hybridization. In situ hybridization for APT1 was performed as described in ref. 50 with a specific digoxigenin-labelled RNA riboprobe (992 nucleotides) sub-cloned into pBluescript II Sk + (Stratagene) vector for transcription. For detection of endogenous miRNAs in dissociated neurons we basically followed the in situ hybridization protocol described in ref. 48 . Fluorescein isothiocyanate (FITC)-conjugated complementary LNA probes (Exiqon) were hybridized overnight with miRNAs at 50 °C. The signal intensity of the FITC probe was amplified with the Alexa Fluor 488 Signal Amplification Kit (Molecular Probes). MAP2 immunostaining (mouse monoclonal; Sigma) was used to reveal dendrites.
Quantitative real-time PCR. Quantitative real-time PCR was performed with the 7300 Real Time PCR System (Applied Biosystems), using the iTaq SybrGreen Supermix with ROX (Bio-Rad) for the detection of mRNAs and the specific TaqMan MicroRNA Assay kits (Applied Biosystems) for the detection of small RNAs (PE Applied Biosystems).
Immunocytochemistry. Hippocampal neurons (17-18 DIV) were fixed in 4% paraformaldehyde for 15 min, permeabilized with PBS plus 0.2% Triton X-100 and blocked in PBS containing 10% normal goat serum. We used a mouse monoclonal anti-PSD95 antibody (1:500; MA1-046; Dianova), a rabbit polyclonal anti-synapsin-1 antibody (1:500; Chemicon), a rabbit polyclonal anti-APT1 antibody (1:50; produced by BioGenes) or a rabbit anti-haemagglutinin antibody (1:2,000; ab9110; Abcam) together with Cy3/Cy5-conjugated anti-mouse/rabbit antibodies (1:400; Jackson Immuno Research). GluR2 surface staining was performed as described 49 .
Cell fractionation. Cells were scraped into ice-cold hypotonic buffer (5 mM Tris-HCl pH 7.5, 1 mM MgCl 2 , 1 mM EGTA, 0.1 mM EDTA) containing protease inhibitors (Complete Mini EDTA-free; Roche). After incubation for 30 min on ice, the lysate was passed ten times through a 20-gauge needle and centrifuged at 3,000g for 15 min to remove nuclear debris. The lysate was centrifuged again for 1 h at 150,000g. The supernatant (cytosolic fraction) was collected and the pellet (membrane fraction) was resuspended in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% Triton-X-100, 0.2% SDS) containing protease inhibitors.
Application of APT1 inhibitors. Small-molecule APT1 inhibitors (FD196, FD253 and RB020) were diluted and stored in DMSO at 10 mM. Inhibitors were pre-diluted in medium and subsequently added to the cells at a final concentration of 10 µM. The treatment was repeated every 60 min because of the high hydrolysis rate of the inhibitors. As control we added equivalent volumes of DMSO. A detailed characterization of the APT1 inhibitors will be published elsewhere. and different pSuper-shRNA constructs. 100 ng/ml of a cDNA expression vector for rat APT1-GFP was transfected together with the indicated shRNAs targeting either APT1 (shRNA 1-4) or an unrelated control sequence (control shRNA). Western blots were probed with both a polyclonal anti-APT1 antiserum or a monoclonal anti-EAA-1 antibody as a loading control. Quantification of three blots based on independent experiments is shown at the bottom (vector only control = 1). (B) Dose-dependent knockdown of endogenous APT1 protein in neurons. Cortical neurons were nucleofected with 2 µg of GFP, 1-2 µg of APT1 shRNA-3 or 2 µg of a control shRNA. Western blot was probed with a polyclonal anti-APT1 antiserum or anti-β-Actin as a loading control. (C) Hippocampal neurons transfected as in Figure 5B were stained at 18 DIV for the post-synaptic density marker protein PSD-95 (red). Representative dendritic segments illustrate that mushroom spines in control shRNA transfected neurons are vastly PSD-95 positive (arrowheads in lower panels), whereas the majority of protrusions in APT1-shRNA-1 transfected neurons lack PSD-95. Instead, PSD-95 puncta accumulate on the dendritic shaft (arrowheads in upper panel). Scale bar = 10 µm. (D, E) Quantification of results obtained with neurons treated as in (C). Bars in (D) represent the ratio of spines containing PSD-95 puncta to the total number of dendritic protrusions for each experimental condition. Bars in (E) represent the overall density of PSD-95 puncta within a defined dendritic area (1 µm 2 ) for each experimental condition. For each experiment, a total of eight neurons grown on two replicate coverslips were analyzed. *p<0.05 (t-test). Primary hippocampal neurons were transfected with GFP together with constructs expressing HA-tagged wt Gα13 (A), the palmitoylation-defective Gα13 CCSS mutant (B) or the constitutively membrane-attached myr Gα13 CCSS mutant (C). Anti-HA staining (red, 18DIV) reveals Gα13 localization in dendritic protrusions (arrowheads) only for wt Gα13 and myr Gα13 CCSS. Cell nuclei were visualized by DAPI counterstain (blue). Scale bar = 10 µm.
(D) Model for the role of miRNAs in the regulation of G protein signaling and dendritic spine morphogenesis. As previously shown, miR-132 and miR-134 antagonistically regulate the activity of the spine growth promoting Rac signaling pathway. In addition, miR-138 might activate the Rho signaling pathway implicated in spine shrinkage by promoting membrane-association of Gα12/13. ROK: Rho-associated kinase. Limk1: Lim-domain containing protein kinase 1. 
Microarray analysis
Total RNA extracted from rat P15 whole brain and fractionated P15 synaptosomes was Cy3-and Cy5-labeled, respectively, and hybridized to a miRNA microarray (LC Sciences, Austin, USA) comprising three replica of DNA probes for all annotated miRNAs from mouse (Mus musculus) and rat (Rattus norvegicus) in the miRBase Release 7.0 as well as a set of non experimentally verified probes, assigned S, corresponding to the miRNA* strand of the annotated mature miRNA sequences. Fluorochrome-labeled RNA samples from three independent experiments were hybridized to the microarray and the array data was analyzed using the TIGR MIDAS software package (www.tm4.org). Scanned array images were imported into TIGR Spotfinder version 3.1 for the extraction of integrated Cy3 and Cy5 intensities.
Ratios of log-transformed integrated intensities were Lowess (LocFit) normalized using TIGR MIDAS version 2.19. Intensities of replica probes were averaged using Microsoft Excel excluding probes displaying a coefficient of
